Abstract
Clinicians today face challenges in dealing with the complexity of data, as
deriving meaningful insights from it requires a lot of time and effort. In this scenario,
artificial intelligence (AI) holds tremendous promise. To deal with a large amount of
data, AI would certainly offer new ways to provide clinical decision support as well as
it will speed up the workflow. Generation of large data through the cancer
nanomedicine programme, AI would be of great help to clinicians.
Keywords: Artificial intelligence, Cancer nanomedicine, Nanomedicine, Nanotechnology, Target site.